Vyome Holdings, Inc
HIND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427570
No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 12
- 13F valueReported value at the end of Q2 2026
- $296.5K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding HIND, Q2 2026
No superinvestor reported holding HIND at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Vyome Holdings, Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2024 (view filing)4:29 PM ET | Nov 30, 2023-May 31, 2024 | 257 daysLate | Stankovich ThomasChief Financial Officer | SSaleCommon Stock, $0.001 par value per share | −172 | $0.2255 | −$38.78 | −0.7%22.8K after | 4 lots |
| Nov 8, 2023 (view filing)4:16 PM ET | Aug 4-Oct 25 | 96 daysLate | Stankovich ThomasChief Financial Officer | SSaleCommon Stock, $0.001 par value per share | −435 | $0.8885 | −$386.48 | −1.9%22.9K after | 5 lots |
| Jul 19, 2023 (view filing) | Jul 6 | 13 daysLate | Stankovich ThomasChief Financial Officer | SSaleCommon Stock, $0.001 par value per share | −106 | $1.47 | −$155.82 | −0.5%23.4K after | |
| Jul 6, 2023 (view filing) | Mar 31-May 31 | 97 daysLate | Stankovich ThomasChief Financial Officer | SSaleCommon Stock, $0.001 par value per share | −303 | $2.46 | −$746.14 | −5.0%5.79K after | 3 lots |
| Jul 6, 2023 (view filing) | Jun 30 | 6 daysLate | Stankovich ThomasChief Financial Officer | PPurchaseCommon Stock, $0.001 par value per share | +17.7K | $1.52 | +$26.9K | +305.8%23.5K after | |
| Mar 7, 2023 (view filing) | Jan 24-Feb 28 | 42 daysLate | Stankovich ThomasChief Financial Officer | SSaleCommon Stock, $0.001 par value per share | −418 | $8.87 | −$3.71K | −6.4%6.09K after | 4 lots |
| Dec 20, 2022 (view filing)4:35 PM ET | Nov 28-Dec 1 | 22 daysLate | Stankovich ThomasChief Financial Officer | SSaleCommon Stock, $0.001 par value per share | −372.1K | $0.1691 | −$62.9K | −53.3%325.4K after | 3 lots |
| Nov 10, 2022 (view filing)4:10 PM ET | Nov 4 | 6 daysLate | Stankovich ThomasChief Financial Officer | SSaleCommon Stock, $0.001 par value per share | −8.39K | $0.2725 | −$2.29K | −2.5%332.8K after | 2 lots |
| Oct 6, 2022 (view filing)5:29 PM ET | Oct 4 | 2 days | Stankovich ThomasCFO | SSaleCommon Stock, $0.001 par value per share | −8.29K | $0.2809 | −$2.33K | −2.4%338.7K after | 2 lots |
| Sep 12, 2022 (view filing)4:05 PM ET | Sep 6 | 6 daysLate | Stankovich ThomasChief Financial Officer | SSaleCommon Stock, $0.001 par value per share | −4.83K | $0.39 | −$1.88K | −1.4%347.0K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Vyome Holdings, Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 25,972 | $55.8K | 0.00% | +25,972 | New |
| Geode Capital Management, LLC | 25,793 | $55.5K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 20,318 | $43.0K | 0.00% | +20,318 | New |
| Colony Group, LLC | 14,640 | $31.5K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 12,195 | $26.2K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,908 | $25.6K | 0.00% | −10,767−47.5% | Reduced |
| Susquehanna International Group, LLP | 10,058 | $21.6K | 0.00% | +10,058 | New |
| Vanguard Capital Management LLC | 9,463 | $20.3K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5,856 | $13.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,808 | $3.89K | 0.00% | +417+30.0% | Added |